Genome-Wide Association Study (GWAS) Of Event-Free Survival In Diffuse Large B-Cell Lumphoma (DLBCL) Treated With Rituximab and Anthracycline-Based Chemotherapy: A Lysa and Iowa/Mayo Clinic SPORE Multistage Study

被引：0
|
作者：
Ghesquieres, Herve
Slager, Susan L.
Jardin, Fabrice
Veron, Amelie S.
Novak, Anne
Maurer, Matthew J.
Fest, Thierry
Habermann, Thomas M.
Bene, Marie C.
Haioun, Corinne
Lamy, Thierry
Ansell, Stephen M.
Tilly, Herve
Witzig, Thomas E.
Feldman, Andrew L.
Dogan, Ahmet
Cunningham, Julie M.
Olswold, Curtis L.
Asmann, Yan W.
Molina, Thierry Jo
Link, Brian K.
Milpied, Noel
Cox, David G.
Salles, Gilles Andre
Cerhan, James R.
机构：
来源：
BLOOD | 2013年 / 122卷 / 21期
关键词：
D O I：
10.1182/blood.V122.21.76.76
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
76
引用
收藏
页数：2
相关论文
共 7 条
  • [1] Genome-Wide Association Study of Event-Free Survival in Diffuse Large B-Cell Lymphoma Treated With Immunochemotherapy
    Ghesquieres, Herve
    Slager, Susan L.
    Jardin, Fabrice
    Veron, Amelie S.
    Asmann, Yan W.
    Maurer, Matthew J.
    Fest, Thierry
    Habermann, Thomas M.
    Bene, Marie C.
    Novak, Anne J.
    Mareschal, Sylvain
    Haioun, Corinne
    Lamy, Thierry
    Ansell, Stephen M.
    Tilly, Herve
    Witzig, Thomas E.
    Weiner, George J.
    Feldman, Andrew L.
    Dogan, Ahmet
    Cunningham, Julie M.
    Olswold, Curtis L.
    Molina, Thierry Jo
    Link, Brian K.
    Milpied, Noel
    Cox, David G.
    Salles, Gilles A.
    Cerhan, James R.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (33) : 3930 - +
  • [2] A Genome-Wide Association Study (GWAS) of Event-Free Survival (EFS) in Follicular Lymphoma Patients Treated with Front-Line Immunochemotherapy: A Lysa, Iowa/Mayo MER, and FIL Study
    Ghesquieres, Herve
    Drouet, Youenn
    Slager, Susan L.
    Morschhauser, Franck
    Galimberti, Sara
    Robinson, Dennis P.
    Thomas, Emilie
    Novak, Anne J.
    Xerri, Luc
    Luminari, Stefano
    Verney, Aurelie
    Laurent, Camille
    Rimsza, Lisa M.
    Habermann, Thomas M.
    Federico, Massimo
    Link, Brian K.
    Salles, Gilles
    Cerhan, James R.
    [J]. BLOOD, 2022, 140 : 1307 - 1309
  • [3] LMO2 protein expression predicts survival in patients with diffuse large B-cell lymphoma treated with anthracycline-based chemotherapy with or without rituximab
    Natkunam, Y.
    Farinha, P.
    Hsi, E. D.
    Hans, C. P.
    Tibshirani, R.
    Sehn, L. H.
    Connors, J. M.
    Gratzinger, D.
    Zhao, S.
    Pohlman, B.
    Nagler, A.
    Levy, R.
    Gascoyne, R. D.
    Lossos, I. S.
    [J]. LABORATORY INVESTIGATION, 2008, 88 : 267A - 267A
  • [4] LMO2 protein expression predicts survival in patients with diffuse large B-Cell lymphoma treated with anthracycline-based chemotherapy with and without rituximab
    Natkunam, Yasodha
    Farinha, Pedro
    Hsi, Eric D.
    Hans, Christine P.
    Tibshirani, Robert
    Sehn, Laurie H.
    Connors, Joseph M.
    Gratzinger, Dita
    Rosado, Manuel
    Zhao, Shuchun
    Pohlman, Brad
    Wongchaowart, Nicholas
    Bast, Martin
    Avigdor, Abraham
    Schiby, Ginette
    Nagler, Arnon
    Byrne, Gerald E.
    Levy, Ronald
    Gascoyne, Randy D.
    Lossos, Izidore S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (03) : 447 - 454
  • [5] LMO2 protein expression predicts survival in patients with diffuse large B-cell lymphoma treated with anthracycline-based chemotherapy with or without rituximab
    Natkunam, Y.
    Farinha, P.
    Hsi, E. D.
    Hans, C. P.
    Tibshirani, R.
    Sehn, L. H.
    Connors, J. M.
    Gratzinger, D.
    Zhan, S.
    Pohlman, B.
    Nagler, A.
    Levy, R.
    Gascoyne, R. D.
    Lossos, I. S.
    [J]. MODERN PATHOLOGY, 2008, 21 : 267A - 267A
  • [6] Age is the most important predictor of survival in diffuse large B-cell lymphoma patients achieving event-free survival at 24 months: a Swedish population-based study
    Abu Sabaa, Amal
    Morth, Charlott
    Hasselblom, Sverker
    Hedstrom, Gustaf
    Flogegard, Max
    Stern, Mimmi
    Andersson, Per-Ola
    Glimelius, Ingrid
    Enblad, Gunilla
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2021, 193 (05) : 906 - 914
  • [7] The Impact of Pre-Therapeutic Haemoglobin Levels on the Outcome of Patients with Diffuse Large B-Cell Lymphoma Treated with Anthracycline Containing Chemotherapy before and after the Introduction of Rituximab: A Nation-Wide Cohort Study
    Clausen, Michael Roost
    Ulrichsen, Sinna Pilgaard
    Larsen, Thomas Stauffer
    Himmelstrup, Bodil
    Ronnov-Jessen, Dorthe
    Pedersen, Per Trollund
    Madsen, Jakob
    Pedersen, Robert Schou
    Josefsson, Par
    Gorlov, Jette Sonderskov
    Norgaard, Mette
    d'Amore, Francesco
    [J]. BLOOD, 2017, 130
1